To Curb the Progression of Fatal COVID-19 Course-Dream or Reality
- PMID: 33638064
- PMCID: PMC7910199
- DOI: 10.1007/s11906-021-01130-z
To Curb the Progression of Fatal COVID-19 Course-Dream or Reality
Abstract
Purpose of review: To analyze the impact of sodium retention states on the course of COVID-19 and propose possible interventions to curb disease progression.
Recent findings: Numerous data confirm a positive association of non-communicable diseases, aging, and other sodium-retaining states, including iatrogenic ones, with more severe sometimes fatal clinical course of COVID-19. Reasons for this effect could include increased angiotensin signaling via the AT1R receptor. The endothelial glycocalyx also plays an important role in infection, leading to a vicious cycle of inflammation and tissue sodium retention when damaged. RAS inhibitors may help restore glycocalyx function and prevent severe organ damage. Anticoagulants, especially heparin, may also have therapeutic applications due to antithrombotic, anti-inflammatory, glycocalyx-repairing, and antialdosteronic properties. The ambiguous influence of some diuretics on sodium balance was also discussed. Abnormal sodium storage and increased angiotensin-converting enzyme activity are related to the severity of COVID-19. Inducing sodium removal and reducing intake might improve outcomes.
Keywords: ACEI/ARB; COVID-19; Glycocalyx; Heparin; Spironolactone.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.Am Heart J. 2021 Oct;240:46-57. doi: 10.1016/j.ahj.2021.06.004. Epub 2021 Jun 12. Am Heart J. 2021. PMID: 34126079 Free PMC article.
-
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.Curr Cardiol Rep. 2020 Apr 14;22(5):31. doi: 10.1007/s11886-020-01291-4. Curr Cardiol Rep. 2020. PMID: 32291526 Free PMC article. Review.
-
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.PLoS Comput Biol. 2020 Oct 8;16(10):e1008235. doi: 10.1371/journal.pcbi.1008235. eCollection 2020 Oct. PLoS Comput Biol. 2020. PMID: 33031368 Free PMC article.
-
Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.J Int Med Res. 2020 Dec;48(12):300060520979151. doi: 10.1177/0300060520979151. J Int Med Res. 2020. PMID: 33322988 Free PMC article.
-
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):983-990. doi: 10.1016/j.dsx.2020.06.047. Epub 2020 Jun 27. Diabetes Metab Syndr. 2020. PMID: 32615377 Free PMC article.
Cited by
-
An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic.Med Hypotheses. 2022 Sep;166:110903. doi: 10.1016/j.mehy.2022.110903. Epub 2022 Jul 1. Med Hypotheses. 2022. PMID: 35791352 Free PMC article.
-
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium.J Transl Med. 2021 Dec 3;19(1):491. doi: 10.1186/s12967-021-03163-z. J Transl Med. 2021. PMID: 34861865 Free PMC article.
References
-
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
-
- Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell LF, Chernyak Y, Tobin K, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv 2020; : 2020.04.08.20057794. 10.1101/2020.04.08.20057794 - PubMed
-
- Targoński R, Sadowski J, Price S, Targoński R. Sodium-induced inflammation—an invisible player in resistant hypertension. Hypertens Res e-pub ahead of print 2020; 10.1038/s41440-020-0428-y. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials